281 related articles for article (PubMed ID: 26847174)
21. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
22. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.
Hoxha E; Harendza S; Pinnschmidt HO; Tomas NM; Helmchen U; Panzer U; Stahl RA
Nephrol Dial Transplant; 2015 Nov; 30(11):1862-9. PubMed ID: 26142398
[TBL] [Abstract][Full Text] [Related]
24. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
[TBL] [Abstract][Full Text] [Related]
27. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
[TBL] [Abstract][Full Text] [Related]
28. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
[TBL] [Abstract][Full Text] [Related]
29. A Proposal for a Serology-Based Approach to Membranous Nephropathy.
De Vriese AS; Glassock RJ; Nath KA; Sethi S; Fervenza FC
J Am Soc Nephrol; 2017 Feb; 28(2):421-430. PubMed ID: 27777266
[TBL] [Abstract][Full Text] [Related]
30. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
31. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Primary Membranous Nephropathy.
Gu Y; Xu H; Tang D
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808418
[TBL] [Abstract][Full Text] [Related]
33. Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach.
L'Imperio V; Pieruzzi FG; Sinico RA; Nebuloni M; Tosoni A; Granata A; Santoro D; Capelli I; Garozzo M; Casano S; Smith A; Radice A; Pagni F
Appl Immunohistochem Mol Morphol; 2020; 28(5):376-383. PubMed ID: 30925495
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.
Iwakura T; Ohashi N; Kato A; Baba S; Yasuda H
PLoS One; 2015; 10(9):e0138841. PubMed ID: 26393352
[TBL] [Abstract][Full Text] [Related]
36. Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients.
Wang G; Sun L; Dong H; Wang Y; Xu X; Zhao Z; Cheng W; Liu X; Zhao X; Geng Y; Bao S; Chen Y; Cheng H
Clin J Am Soc Nephrol; 2021 May; 16(5):727-735. PubMed ID: 33849930
[TBL] [Abstract][Full Text] [Related]
37. Unmet challenges in membranous nephropathy.
Salant DJ
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
[TBL] [Abstract][Full Text] [Related]
38. Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study.
Sharma SG; Larsen CP
Mod Pathol; 2018 Apr; 31(4):616-622. PubMed ID: 29243738
[TBL] [Abstract][Full Text] [Related]
39. Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy.
Cossey LN; Walker PD; Larsen CP
Pediatr Nephrol; 2013 Dec; 28(12):2307-11. PubMed ID: 23903693
[TBL] [Abstract][Full Text] [Related]
40. Profile of Indian Patients With Membranous Nephropathy.
Subramanian P; Kumar H; Tiwari B; Barwad A; Bagchi S; Bagga A; Agarwal SK; Dinda AK; Singh G
Kidney Int Rep; 2020 Sep; 5(9):1551-1557. PubMed ID: 32954080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
